Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| NanoVibronix Inc | NAOV | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.75 | 04:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.75 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.6775 - 4.34 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.75 | USD |
NanoVibronix Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.53M | 2.05M | - | 2.28M | -3.71M | -1.81 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
NanoVibronix News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NAOV Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.75 | 0.789 | 0.71 | 0.7345764 | 25,787 | 0.00 | 0.00% |
| 1 Month | 0.762 | 0.8425 | 0.6775 | 0.7085448 | 60,809 | -0.012 | -1.57% |
| 3 Months | 1.04 | 1.04 | 0.6775 | 0.7955121 | 39,365 | -0.29 | -27.88% |
| 6 Months | 1.40 | 1.52 | 0.6775 | 0.9933928 | 72,846 | -0.65 | -46.43% |
| 1 Year | 3.56 | 4.34 | 0.6775 | 2.29 | 436,054 | -2.81 | -78.93% |
| 3 Years | 17.17 | 83.80 | 0.6775 | 43.40 | 2,585,609 | -16.42 | -95.63% |
| 5 Years | 90.00 | 95.00 | 0.6775 | 37.54 | 2,193,528 | -89.25 | -99.17% |
NanoVibronix Description
| NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low frequency, low intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements. |
